Pioneered fundamental and translational discoveries in the neural control of the gastrointestinal tract in health and disease. His innovative research has provided significant insights into the etiology and treatment of inflammatory bowel disease (IBD). Expert in the endocannabinoid system of the gut, he has used his knowledge of cannabinoid biology to advise Health Canada. A tireless community volunteer as Crohn's and Colitis Canada Chair in IBD Research. For his international leadership, editorial abilities and commitment to advance gastrointestinal health, he has been recognized with ...

Professor and Director, Clinical Research Unit, University of Calgary

Dr. Wiebe is an internationally recognized clinical researcher focusing on neurosciences and epilepsy and in evidence based medicine. He specializes in surgical randomized controlled trials, and in patient-centred outcomes. He performed the only randomized trial on brain surgery for epilepsy, which resulted in international treatment guidelines for this condition. Dr. Wiebe has trained numerous clinical researchers, he leads national and international clinical research initiatives, and he plays a major role in establishing educational and clinical care programs in epilepsy around the world.

Dr Prakesh Shah is Pediatrician-in-Chief at Mount Sinai Hospital, Toronto and Professor in the Department of Pediatrics at University of Toronto, Canada. He is the Director of the Canadian Preterm Birth Network (CPTBN) and an International Network for Evaluation of Outcomes of Neonates (iNeo) whereby he oversees a project of benchmarking outcomes of very preterm neonates in 13 countries including 300 NICUs. His areas of interest include Patient and Disease oriented research in NeonatalPerinatal Medicine, Health Services and Epidemiological Research in Maternal-Newborn care and Quality ...

Professor - Chemistry and Biomaterials & Biomedical Engineer, University of Toronto

Professor, Department of Chemical Engineering and Applied Chemistry, Department of Chemistry, Institute of Biomaterials and Biomedical Engineering, University of Toronto Molly Shoichet is world-renowned for her regenerative medicine research in the central nervous system. With a passion for translational research, Shoichet has designed innovative bioengineered strategies to promote tissue repair after traumatic spinal cord injury, stroke and blindness. Through multidisciplinary collaborations, Shoichet has advanced local delivery to the brain to stimulate the resident stem cells therein, ...

Emeritus Professor, University of Calgary

Eldon R. Smith became Chief of Cardiology at the University of Calgary in 1980. He later served as Chairman of Medicine and Associate Dean before becoming Dean of the Faculty in 1992. He has been President of the Canadian Cardiovascular Society and the Association of Canadian Medical Colleges. He is Director and President of the Peter Lougheed Medical Research Foundation and a Trustee of the Alberta Heritage Foundation for Medical Research. He has received numerous awards and recognitions including the 125th Anniversary of Canada Medal, the CMA Medal of Service, and the Order of the ...

Retired President and Chief Executive Officer, Alberta Heritage Foundation for Medical Research

Matthew Spence served as President and Chief Executive Officer of the Alberta Heritage Foundation for Medical Research (AHFMR) from 1990 to 2004. Trained in neurobiochemistry, he was on faculty at McGill and Dalhousie Universities. In Halifax, he was Director of the Atlantic Research Centre for Mental Retardation, Professor of Paediatrics and Biochemistry at Dalhousie University School of Medicine, a Medical Research Council of Canada Career Investigator, and Chief of Research and a member of the active staff of the lzaak Walton Killam Hospital for Children. He has served as President of the ...

Jeffrey Turnbull is Professor and Chair of the Department of Medicine at the University of Ottawa and the Ottawa Hospital. He is a leading authority in the field of medical training. Previously, he served as Assistant Dean and subsequently Vice Dean: Education at the University of Ottawa. Over the past several years, Dr. Turnbull has contributed nationally and internationally through the AFMC, the RCPSC, the CMA, the AAMC, the CPSO and as President of the MCC. He has pursued his interest in poverty and its effect on health and is currently the Medical Director of the Inner City Health Project ...

A Professor of Cardiac Surgery, Senior Scientistat the Toronto General Research Institute and a basic and clinical investigatorwhose new techniques of cardiac protection for heart surgery have been adopted worldwide. He discovered stem cell implantation prevented heart failure aftercoronary occlusion which stimulated clinical trials in Toronto and globally. Heis now Editor of the highest ranked Journal and Chair of the largest clinicaltrials network in his specialty. Most important, he trained two generations of Surgical Scientists who have assumed leadership positions in Canada and the world. ...

Dr. Vincent Piguet is an internationally recognized clinician scientist and dermatologist focusing on skin immunology and infection. He has been an invited speaker at over 160 national and international meetings, including the World Congress of Dermatology and Keystone meetings. He has authored 240 peer-reviewed publications including in Cell, Immunity, and The Lancet. He is Deputy Editor for the Journal of Investigative Dermatology, the top research journal in his field. He is the Past-President of the European Society for Dermatological Research and past President Elect of the European ...

Senior Investigator, Lunenfeld-Tanenbaum Research Institute

Jim Woodgett is President and Scientific Director of the Terry Fox Research Institute and Senior Investigator at the Lunenfeld-Tanenbaum Research Institute (LTRI). After a PhD in Scotland with Philip Cohen and postdoctoral studies at the Salk Institute under Tony Hunter he established a lab at the Ludwig Institute for Cancer Research, UK where he cloned and characterized genes for regulators of signaling pathways including the stress-activated protein kinases, PKB/Akt and GSK3. He joined the Ontario Cancer Institute in 1992 studying signalling mechanisms underscoring cancer and other ...